Review Article
Excess Early Mortality in Schizophrenia
- Thomas Munk Laursen1,3,Merete Nordentoft2,3 andPreben Bo Mortensen1,3
- View Affiliations and Author NotesHide Affiliations and Author Notes1National Center for Register-Based Research, Aarhus University, 8210 Aarhus V, Denmark; email:[email protected]2Psychiatric Center Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, DK 2200 Denmark3The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPsych), 8210 Aarhus V, Denmark
- Vol. 10:425-448(Volume publication date March 2014)
- First published as a Review in Advance onDecember 02, 2013
- © Annual Reviews
- View CitationHide Citation
Thomas Munk Laursen, Merete Nordentoft, Preben Bo Mortensen. 2014. Excess Early Mortality in Schizophrenia.Annual Review Clinical Psychology.10:425-448.https://doi.org/10.1146/annurev-clinpsy-032813-153657
Abstract
Schizophrenia is often referred to as one of the most severe mental disorders, primarily because of the very high mortality rates of those with the disorder. This article reviews the literature on excess early mortality in persons with schizophrenia and suggests reasons for the high mortality as well as possible ways to reduce it. Persons with schizophrenia have an exceptionally short life expectancy. High mortality is found in all age groups, resulting in a life expectancy of approximately 20 years below that of the general population. Evidence suggests that persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during the past decades. Thus, the mortality gap not only persists but may actually have increased. The most urgent research agenda concerns primary candidates for modifiable risk factors contributing to this excess mortality, i.e., side effects of treatment and lifestyle factors, as well as sufficient prevention and treatment of physical comorbidity.





